Berkeley Lights, Inc., a cell biology company, operates in enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products in North America, the Asia Pacific, and Europe. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.
Research context
Berkeley Lights Inc appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Biotechnology & Medical Research
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Berkeley Lights, Inc is currently in a long term downtrend where the price is trading 29.8% below its 200 day moving average.
From a valuation standpoint, the stock is 98.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 23.7.
Based on the above factors, Berkeley Lights, Inc gets an overall score of 1/5.